Multiple sclerosis trials in Georgia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  Where

  Tbilisi

  Age

  18 years to 60 years

  People

  705 worldwide

  Run by

  Zenas BioPharma (USA), LLC

  See details and how to joinNCT07067463 · EU 2025-524316-11-00
• Phase 3Taking people
  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Where

  Tbilisi

  Age

  18 years to 60 years

  People

  990 worldwide

  Run by

  Zenas BioPharma (USA), LLC

  See details and how to joinNCT07299019 · EU 2025-524322-18-00
• Phase 2Taking people
  A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

  Where

  Rustavi, Tbilisi

  Age

  18 years to 65 years

  People

  350 worldwide

  Run by

  TG Therapeutics, Inc.

  See details and how to joinNCT07503873 · EU 2025-523757-33-00